These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. A randomized trial comparing intravenous immunoglobulin and plasma exchange in Guillain-Barré syndrome. Kleyweg RP; van der Meché FG; Schmitz PI Transfus Sci; 1994 Dec; 15(4):389-92. PubMed ID: 10172508 [No Abstract] [Full Text] [Related]
6. The Guillain-Barré syndrome: plasma exchange or immunoglobulins intravenously. van der Meché FG J Neurol Neurosurg Psychiatry; 1994 Nov; 57 Suppl(Suppl):33-4. PubMed ID: 7964849 [No Abstract] [Full Text] [Related]
7. Second response to immunoglobulin in recurrent Guillain-Barré syndrome. Nagappan R; Barker J N Z Med J; 1998 Nov; 111(1077):433-4. PubMed ID: 9861925 [TBL] [Abstract][Full Text] [Related]
8. The Guillain-Barré syndrome: plasma exchange or immunoglobulins intravenously? van der Meché FG Ann Med Interne (Paris); 1994; 145(5):293-5. PubMed ID: 7985934 [No Abstract] [Full Text] [Related]
9. [Intravenous immunoglobulins in Guillain-Barré syndrome]. Hidou M; Olivier J; Vivant JF Ann Fr Anesth Reanim; 1992; 11(1):115. PubMed ID: 1443803 [No Abstract] [Full Text] [Related]
10. Guillain-Barré syndrome: the evolution of therapy. Cornblath DR; Hughes RA J Neurol; 1994 May; 241(6):404-5. PubMed ID: 7931438 [No Abstract] [Full Text] [Related]
11. Is there a scientific rationale for therapeutic plasma exchange or intravenous immune globulin in the treatment of acute Guillain-Barré syndrome? Weinstein R J Clin Apher; 1995; 10(3):150-7. PubMed ID: 8582898 [No Abstract] [Full Text] [Related]
12. Plasma exchange versus intravenous immunoglobulin for Guillain-Barré syndrome. Hughes RA Ther Apher; 1997 May; 1(2):129-30. PubMed ID: 10225757 [TBL] [Abstract][Full Text] [Related]
13. Pilot trial of immunoglobulin versus plasma exchange in patients with Guillain-Barré syndrome. Bril V; Ilse WK; Pearce R; Dhanani A; Sutton D; Kong K Neurology; 1996 Jan; 46(1):100-3. PubMed ID: 8559353 [TBL] [Abstract][Full Text] [Related]
17. Risk factors for treatment related clinical fluctuations in Guillain-Barré syndrome. Rees JH J Neurol Neurosurg Psychiatry; 1998 Feb; 64(2):148-9. PubMed ID: 9489520 [No Abstract] [Full Text] [Related]
18. Treatment related fluctuations in Guillain-Barré syndrome after high-dose immunoglobulins or plasma-exchange. Kleyweg RP; van der Meché FG J Neurol Neurosurg Psychiatry; 1991 Nov; 54(11):957-60. PubMed ID: 1800666 [TBL] [Abstract][Full Text] [Related]
19. [Value of intravenous immunoglobulins. A case of Guillain-Barré syndrome]. Hidou M; Olivier J; Vivant JF Rev Neurol (Paris); 1992; 148(11):706-8. PubMed ID: 1303562 [TBL] [Abstract][Full Text] [Related]
20. The Italian Guillain-Barré Study Group. The prognosis and main prognostic indicators of Guillain-Barré syndrome: a multicentre prospective study of 297 patients. Hughes RA; Hadden RD; Rees JH; Swan AV Brain; 1998 Apr; 121 ( Pt 4)():767-9. PubMed ID: 9577400 [No Abstract] [Full Text] [Related] [Next] [New Search]